Venlafaxine as an Adjuvant Therapy for Inflammatory Bowel Disease Patients With Anxious and Depressive Symptoms: A Randomized Controlled Trial

BACKGROUND AND AIMS: The effect of antidepressant therapy on Inflammatory Bowel Disease (IBD) remains controversial. This trial aimed to assess whether adding venlafaxine to standard therapy for IBD improved the quality of life (QoL), mental health, and disease activity of patients with IBD with anx...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Chang, Chen, Pingrun, Tang, Yu, Zhang, Chuheng, Lei, Na, Luo, Ying, Duan, Shihao, Zhang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160994/
https://www.ncbi.nlm.nih.gov/pubmed/35664492
http://dx.doi.org/10.3389/fpsyt.2022.880058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160994/
https://www.ncbi.nlm.nih.gov/pubmed/35664492
http://dx.doi.org/10.3389/fpsyt.2022.880058

Ejemplares similares